- Home
- SOPH vs XBIT Comparison
SOPH vs XBIT Comparison
Compare SOPH & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOPH | XBIT |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Pharmaceuticals and Biotechnology |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.7M | 71.3M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SOPH | XBIT |
|---|---|---|
| Price | $4.71 | $2.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 104.4K | 46.4K |
| Earning Date | 03-03-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $23.09 | N/A |
| Revenue Next Year | $19.57 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.58 | $2.09 |
| 52 Week High | $5.70 | $3.62 |
Technical Indicators
Market Signals| Indicator | SOPH | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 48.36 | 41.26 |
| Support Level | $4.54 | $2.15 |
| Resistance Level | $4.86 | $2.69 |
| Average True Range (ATR) | 0.28 | 0.07 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 36.63 | 26.33 |
Price Performance
Historical ComparisonAbout SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.